Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

Eli Lilly HQ

Latecomer Lilly preps its IL-23 drug for Crohn’s disease

Hopes to leapfrog rivals

- PMLiVE

Verily unveils next-gen trials alliance with Novartis, Pfizer

New data methods and tech will be used to streamline trials

- PMLiVE

Focusing on patient-centricity to build trust in pharma

By Marianne Guldbrandsen

- PMLiVE

An increasingly polarised world offers the opportunity for healthcare organisations to build trust by turning inwards

By Dr Eleanor Read

- PMLiVE

Huntsworth bolsters market access capabilities with Creativ-Ceutical

Adds new capabilities and global presence

- PMLiVE

As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority

Eurosceptics want to block greater EU integration

- PMLiVE

Research charity LifeArc cashes $1.2bn royalty from Keytruda

UK medical research charity pledges to expand its work

- PMLiVE

No deal or revoke looming as fourth vote on Brexit nears

Voters set to protest via EU elections, no-deal remains possibility

- PMLiVE

Boehringer eyes rare disease use for respiratory blockbuster

Would help support respiratory franchise

- PMLiVE

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Bedrock Healthcare Communications

Graphic inspired by back to the future

The Exhibition Hall: Past, Present and Future

As I sit here at another pharma conference, I start to reflect on how they have changed over the years.

Cuttsy + Cuttsy

- PMLiVE

Keytruda monotherapy fails in triple negative breast cancer

Fails in gambit to outflank rival Tecentriq

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links